136 related articles for article (PubMed ID: 31711435)
61. The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China.
Chen W; Sun H; Molijn A; Zeng L; Kang L; Jenkins D; Zhang S; Cui J; Wu Z; Pirog E; Shen G; Zhang X; Qiao Y;
J Low Genit Tract Dis; 2018 Oct; 22(4):355-361. PubMed ID: 30074955
[TBL] [Abstract][Full Text] [Related]
62. Extended Human Papillomavirus Genotype Distribution and Cervical Cytology Results in a Large Cohort of Chinese Women With Invasive Cervical Cancers and High-Grade Squamous Intraepithelial Lesions.
Jiang W; Marshall Austin R; Li L; Yang K; Zhao C
Am J Clin Pathol; 2018 May; 150(1):43-50. PubMed ID: 29746625
[TBL] [Abstract][Full Text] [Related]
63. Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China.
Zhang L; Xie F; Wang X; Peng D; Bi C; Jiang L; Zhao D; Tian X; Qi D
PLoS One; 2017; 12(6):e0180618. PubMed ID: 28662160
[TBL] [Abstract][Full Text] [Related]
64. Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors.
Pirog EC
Arch Pathol Lab Med; 2017 Dec; 141(12):1653-1667. PubMed ID: 28644686
[TBL] [Abstract][Full Text] [Related]
65. Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results.
Tao X; Zheng B; Yin F; Zeng Z; Li Z; Griffith CC; Luo B; Ding X; Zhou X; Zhao C
Am J Clin Pathol; 2017 May; 147(5):477-483. PubMed ID: 28340235
[TBL] [Abstract][Full Text] [Related]
66. Integrated genomic and molecular characterization of cervical cancer.
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Nature; 2017 Mar; 543(7645):378-384. PubMed ID: 28112728
[TBL] [Abstract][Full Text] [Related]
67. Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.
van der Horst J; Siebers AG; Bulten J; Massuger LF; de Kok IM
Cancer Med; 2017 Feb; 6(2):416-423. PubMed ID: 28102052
[TBL] [Abstract][Full Text] [Related]
68. The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China.
Chen W; Molijn A; Enqi W; Zhang X; Jenkins D; Yu X; Quint W; Schmidt JE; Li J; Pirog E; Liu B; Li Q; Liu X; Li L; Qiao Y;
Int J Cancer; 2016 Dec; 139(12):2687-2697. PubMed ID: 27554015
[TBL] [Abstract][Full Text] [Related]
69. The complex relationship between human papillomavirus and cervical adenocarcinoma.
Molijn A; Jenkins D; Chen W; Zhang X; Pirog E; Enqi W; Liu B; Schmidt J; Cui J; Qiao Y; Quint W;
Int J Cancer; 2016 Jan; 138(2):409-16. PubMed ID: 26334557
[TBL] [Abstract][Full Text] [Related]
70. Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study.
Holl K; Nowakowski AM; Powell N; McCluggage WG; Pirog EC; Collas De Souza S; Tjalma WA; Rosenlund M; Fiander A; Castro Sánchez M; Damaskou V; Joura EA; Kirschner B; Koiss R; O'Leary J; Quint W; Reich O; Torné A; Wells M; Rob L; Kolomiets L; Molijn A; Savicheva A; Shipitsyna E; Rosillon D; Jenkins D
Int J Cancer; 2015 Dec; 137(12):2858-68. PubMed ID: 26096203
[TBL] [Abstract][Full Text] [Related]
71. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
72. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
[TBL] [Abstract][Full Text] [Related]
73. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.
Blatt AJ; Kennedy R; Luff RD; Austin RM; Rabin DS
Cancer Cytopathol; 2015 May; 123(5):282-8. PubMed ID: 25864682
[TBL] [Abstract][Full Text] [Related]
74. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
Huh WK; Ault KA; Chelmow D; Davey DD; Goulart RA; Garcia FA; Kinney WK; Massad LS; Mayeaux EJ; Saslow D; Schiffman M; Wentzensen N; Lawson HW; Einstein MH
Gynecol Oncol; 2015 Feb; 136(2):178-82. PubMed ID: 25579107
[TBL] [Abstract][Full Text] [Related]
75. HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases.
Pirog EC; Lloveras B; Molijn A; Tous S; Guimerà N; Alejo M; Clavero O; Klaustermeier J; Jenkins D; Quint WG; Xavier Bosch F; Alemany L; de Sanjosé S;
Mod Pathol; 2014 Dec; 27(12):1559-67. PubMed ID: 24762548
[TBL] [Abstract][Full Text] [Related]
76. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
77. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
Ronco G; Dillner J; Elfström KM; Tunesi S; Snijders PJ; Arbyn M; Kitchener H; Segnan N; Gilham C; Giorgi-Rossi P; Berkhof J; Peto J; Meijer CJ;
Lancet; 2014 Feb; 383(9916):524-32. PubMed ID: 24192252
[TBL] [Abstract][Full Text] [Related]
78. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Massad LS; Einstein MH; Huh WK; Katki HA; Kinney WK; Schiffman M; Solomon D; Wentzensen N; Lawson HW;
Obstet Gynecol; 2013 Apr; 121(4):829-846. PubMed ID: 23635684
[TBL] [Abstract][Full Text] [Related]
79. Human papillomavirus and cervical cancer.
Crosbie EJ; Einstein MH; Franceschi S; Kitchener HC
Lancet; 2013 Sep; 382(9895):889-99. PubMed ID: 23618600
[TBL] [Abstract][Full Text] [Related]
80. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
